TIMI
TIMI
TIMI (pronounced tee-mee), an acronym for Thrombolysis in Myocardial Infarction, is a clinical trial group based in Boston, Massachusetts, USA. The group has conducted several important clinical trials that have influenced the practice of cardiology.
Etymology
The term "TIMI" is derived from the medical procedure it represents, Thrombolysis in Myocardial Infarction. "Thrombolysis" (Greek: θρόμβος, thrómbos, "clot"; λύσις, lýsis, "loosening") refers to the breakdown of blood clots, "myocardial" pertains to the myocardium or the muscular tissue of the heart, and "infarction" (Latin: infarctus, from infarcire, "to stuff") refers to tissue death due to lack of oxygen supply.
Related Terms
- Thrombolysis: The breakdown of blood clots formed in blood vessels, using medication.
- Myocardial Infarction: Commonly known as a heart attack, it is a medical emergency in which blood flow decreases or stops to a part of the heart, causing damage to the heart muscle.
- Cardiology: The study and treatment of disorders of the heart and the blood vessels.
- Clinical Trial: Research investigations in which people volunteer to test new treatments, interventions or tests as a means to prevent, detect, treat or manage various diseases or medical conditions.
See Also
External links
- Medical encyclopedia article on TIMI
- Wikipedia's article - TIMI
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski